The pharmaceutical market in China is set to boom. Some predictions see it growing to $200 billion by 2020, making it the second largest in the world, surpassing Japan along the way. As such, the Chinese market is very attractive for international drug companies, especially because of its aging population, chronic disease growth, expanding healthcare insurance coverage, urbanization and increased investment in rural healthcare services. More importantly, the growing industry is spurring the Chinese government to invest in medical science.